Synergistic and strain-specific effects of bovine spongiform encephalopathy and scrapie prions in the cell-free conversion of recombinant prion protein
This study describes the conversion of murine PrPC by PrPSc from three different mouse scrapie strains (ME7, 87V and 22A) and from a mouse-passaged bovine spongiform encephalopathy (BSE) strain (BSE/Bl6). This was demonstrated by a modified, non-radioactive, cell-free conversion assay using bacterial prion protein, which was converted into a proteinase K (PK)-resistant fragment designated PrPres. Using this assay, newly formed PrPres could be detected by an antibody that discriminated de novo PrPres and the original PrPSc seed. The results suggested that PrPres formation occurs in three phases: the first 48 h when PrPres formation is delayed, followed by a period of substantially accelerated PrPres formation and a plateau phase when a maximum concentration of PrPres is reached after 72 h. The conversion of prokaryotically expressed PrPC by ME7 and BSE prions led to unglycosylated, PK-digested, abnormal PrPres fragments, which differed in molecular mass by 1 kDa. Therefore, prion strain phenotypes were retained in the cell-free conversion, even when recombinant PrPC was used as the substrate. Moreover, co-incubation of ME7 and BSE prions resulted in equal amounts of both ME7- and BSE-derived PrPres fragments (as distinguished by their different molecular sizes) and also in a significantly increased total amount of de novo-generated PrPres. This was found to be more than twice the amount of either strain when incubated separately. This result indicates a synergistic effect of both strains during cell-free conversion. It is not yet known whether such a cooperative action between BSE and scrapie prions also occurs in vivo.
BaronT. G. M.,
BicabeA.-G.2001; Molecular analysis of the abnormal prion protein during coinfection of mice by bovine spongiform encephalopathy and a scrapie agent. J Virol 75:107–114[CrossRef]
BartzJ. C.,
BessenR. A.,
McKenzieD.,
MarshR. F.,
AikenJ. M.2000; Adaption and selection of prion protein strain conformations following interspecies transmission of transmissible mink encephalopathy. J Virol 74:5542–5547[CrossRef]
BaskakovI. V.,
BocharovaO. V.2005; In vitro conversion of mammalian prion protein into amyloid fibrils displays unusual features. Biochemistry 44:2339–2348[CrossRef]
BessenR. A.,
MarshR. F.1992; Biochemical and physical properties of the prion protein from two strains of the transmissble mink encephalopathy agent. J Virol 66:2096–2101
BocharovaO. V.,
BreydoL.,
ParfenovA. S.,
SalnikovV. V.,
BaskakovI. V.2005; In vitro conversion of full-length mammalian prion protein produces amyloid form with physical properties of PrPSc
. J Mol Biol 346:645–659[CrossRef]
BossersA.,
SchreuderB. E.,
MuilemanI. H.,
BeltP. B.,
SmitsM. A.1996; PrP genotype contributes to determining survival times of sheep with natural scrapie. J Gen Virol 77:2669–2673[CrossRef]
BossersA.,
BeltP. B. G. M.,
RaymondG. J.,
CaugheyB.,
de VriesR.,
SmitsM. A.1997; Scrapie susceptibility-linked polymorphisms modulate the in vitro conversion of sheep prion protein to protease-resistant forms. Proc Natl Acad Sci U S A 94:4931–4936[CrossRef]
BossersA.,
de VriesR.,
SmitsM. A.2000; Susceptibility of sheep for scrapie as assessed by in vitro conversion of nine naturally occurring variants of PrP. J Virol 74:1407–1414[CrossRef]
BossersA.,
RighterA.,
de VriesR.,
SmitsM. A.2003; In vitro conversion of normal prion protein into pathologic isoforms. Clin Lab Med 23:227–247[CrossRef]
ButlerD. A.,
ScottM. R. D.,
BockmannJ. M.,
BorcheltD. R.,
TaraboulosA.,
HsiaoK. K.,
KingsburyD. T.,
PrusinerS. B.1988; Scrapie-infected murine neuroblastoma cells produce protease-resistant prion proteins. J Virol 62:1558–1564
CaugheyB.,
RaymondG. J.,
PriolaS. A.,
KociskoD. A.,
RaceR. E.,
BessenR. A.,
LansburyJ. R.,
ChesebroB.1999b; Methods for studying prion protein (PrP) metabolism and the formation of protease-resistant PrP in cell culture and cell-free systems. An update Mol Biotechnol 13:45–55[CrossRef]
ChabryJ.,
PriolaS. A.,
WehrlyK.,
NishioJ.,
HopeJ.,
ChesebroB.1999; Species-independent inhibition of abnormal prion protein (PrP) formation by a peptide containing a conserved PrP sequence. J Virol 73:6245–6250
GroschupM. H.,
KucziusT.2002; Die TSE-Erregerstämme. In Prionen und Prionenkrankheiten pp 117–131 Edited by
HörnlimannB.,
RiesnerD.,
KretzschmarH.
Berlin & New York: Walter de Gruyter;
GroschupM. H.,
HarmeyerS.,
PfaffE.1997; Antigenic features of prion proteins of sheep and other mammalian species. J Immunol Methods 207:89–101[CrossRef]
GroschupM. H.,
JunghansF.,
EidenM.,
KucziusT.2001; Characterization of bovine spongiform encephalopathy and scrapie strains/isolates by immunochemical analysis of PrPSc. In Molecular Pathology of the Prions
. Methods in Molecular Medicinevol. 59 pp 71–83 Edited by
BakerH. F.
Totowa, NJ: Humana Press;
HayashiH. K.,
YokoyamaT.,
TakataM.,
IwamaruY.,
ImamuraM.,
UshikiY. K.,
ShinagawaM.2005; The N-terminal cleavage site of PrPSc from BSE differs from that of PrPSc from scrapie. Biochem Biophys Res Commun 328:1024–1027[CrossRef]
HoriuchiM.,
PriolaS. A.,
ChabryJ.,
CaugheyB.2000; Interactions between heterologous forms of prion protein: binding, inhibition of conversion, and species barriers. Proc Natl Acad Sci U S A 97:5836–5841[CrossRef]
KascsakR. J.,
RubensteinR.,
MerzP. A.,
CarpR. I.,
RobakisN. K.,
WisniewskiH. M.,
DiringerH.1986; Immunological comparison of scrapie-associated fibrils isolated from animals infected with four different scrapie strains. J Virol 59:676–683
KimberlinR. H.,
WalkerC. A.1985; Competition between strains of scrapie depends on the blocking agent being infectious. Intervirology 23:74–81[CrossRef]
KirbyL.,
BirkettC. R. H.,
RudykH.,
GilbertI. H.,
HopeJ.2003; In vitro cell-free conversion of bacterial recombinant PrP to PrPres as a model for conversion. J Gen Virol 84:1013–1020[CrossRef]
KociskoD. A.,
PriolaS. A.,
RaymondG. J.,
ChesebroB.,
LansburyP. T.Jr,
CaugheyB.1995; Species specificity in the cell-free conversion of prion protein to protease-resistant forms: a model for the scrapie species barrier. Proc Natl Acad Sci U S A 92:3923–3927[CrossRef]
KucziusT.,
GroschupM. H.1999; Differences in proteinase K resistance and neuronal deposition of abnormal prion proteins characterize bovine spongifrom encephalopathy (BSE) and scrapie strains. Mol Med 5:406–418
RaymondG. J.,
HopeJ.,
KociskoD. A.& 12 other authors1997; Molecular assessment of the transmissibilities of BSE and scrapie to humans. Nature 388:285–288[CrossRef]
RaymondG. J.,
BossersA.,
RaymondL. D.& 7 other authors2000; Evidence of a molecular barrier limiting susceptibility of humans, cattle and sheep to chronic wasting disease. EMBO J 19:4425–4430[CrossRef]
SaborioG. P.,
PermanneB.,
SotoC.2001; Sensitive detection of pathological prion protein by cyclic amplification of protein misfolding. Nature 411:810–813[CrossRef]
SilveiraJ. R.,
RaymondG. J.,
HughsonA. G.,
RaceR. E.,
SimV. L.,
HayesS. F.,
CaugheyB.2005; The most infectious prion protein particles. Nature 437:257–261[CrossRef]
ZahnR.,
von SchroetterC.,
WuthrichK.1997; Human prion proteins expressed in Escherichia coli and purified by high-affinity column refolding. FEBS Lett 417:400–404[CrossRef]
Synergistic and strain-specific effects of bovine spongiform encephalopathy and scrapie prions in the cell-free conversion of recombinant prion protein